The Texas OAG settled with six subsidiaries of Takeda Pharmaceutical Co. to resolve allegations that the companies committed Medicaid fraud in violation of the Texas Medicaid Fraud Prevention Act (TMFPA). According to the AG’s office, the settlement addresses alleged TMFPA violations raised by a whistleblower in a qui tam lawsuit. The lawsuit alleged that the…

Read More

California AG Rob Bonta, in partnership with the DOJ, settled with four health care providers to resolve allegations that they violated state and federal False Claims Acts through the submission of fraudulent claims to Medi-Cal, California’s Medicaid program. According to AG Bonta, the allegedly fraudulent submissions were part of a scheme to wrongfully retain federal…

Read More

A group of 18 AGs wrote a letter to officials at the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) in support of a proposed rule requiring disclosure of certain ownership or managerial interests of private equity investors and real estate investment trusts (REITs) regarding nursing…

Read More

Advanced Bionics Corporation—a manufacturer and distributor of cochlear implants—entered settlements with six AGs to resolve allegations that the company violated federal and state False Claims Acts by submitting fraudulent claims for reimbursement to federal healthcare programs including Medicaid. According to the settlements, Advanced Bionics allegedly submitted false information to the FDA regarding testing of certain…

Read More

New York AG Letitia James, together with the DOJ, announced settlements with Saratoga Center for Rehabilitation and Skilled Nursing Care, a former 257-bed nursing home, and its owners, unlicensed operator, and landlord (together, “Saratoga Center”) over allegations that the nursing home submitted reimbursement claims for substandard and worthless services to the state’s Medicaid program while…

Read More